Remus Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication regarding completion of dispatch of Annual Report for FY 2022-23, notice convening 08th Annual General Meeting, intimation of e-voting, intimation of record date for dividend and other related information.